| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
37,750,000 |
| Market
Cap: |
458.29(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$5.77 - $16.73 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Liquidia is a biopharmaceutical company focused on the development, manufacturing and commercialization of products with focus directed towards the treatment of pulmonary hypertension (PH). Co. conducts research and manufacturing of products by applying its proprietary PRINT® technology, a particle engineering platform. Co.'s products and candidates for PH include: YUTREPIATM (treprostinil) Inhalation Powder to Treat PAH, which is an inhaled dry powder formulation of treprostinil; and Treprostinil Injection, a Generic Version of Remodulin®, which contains the same active ingredient, same strength, same dosage forms and same inactive ingredient amounts as Remodulin®.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Nea 12 Gp, Llc |
10% Owner |
– – • |
2018-07-30 |
4 |
B |
$11.00 |
$6,000,005 |
D/D |
545,455 |
2,484,870 |
2.45 |
- |
|
| Nea 12 Gp, Llc |
10% Owner |
– – • |
2018-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,928,295 |
1,939,415 |
|
- |
|
| Canaan Partners Viii Llc |
10% Owner |
– – • |
2018-07-30 |
4 |
B |
$11.00 |
$8,000,003 |
D/D |
727,273 |
2,563,303 |
2.45 |
- |
|
| Canaan Partners Viii Llc |
10% Owner |
– – • |
2018-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,833,331 |
1,836,030 |
|
- |
|
| Melmotte Llc |
10% Owner |
– – • |
2018-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
107,791 |
107,791 |
|
- |
|
| Bloch Stephen M |
Director |
– • – |
2018-07-30 |
4 |
B |
$11.00 |
$8,000,003 |
I/I |
727,273 |
2,563,303 |
2.1 |
- |
|
| Bloch Stephen M |
Director |
– • – |
2018-07-30 |
4 |
A |
$0.00 |
$0 |
I/I |
1,833,331 |
1,836,030 |
|
- |
|
| Al Wealth Partners Pte. Ltd. |
10% Owner |
– – • |
2018-07-30 |
4 |
A |
$0.00 |
$0 |
I/I |
151,070 |
151,070 |
|
- |
|
| University Of North Carolina At Chapel Hill Founda |
10% Owner |
– – • |
2018-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
106,276 |
119,880 |
|
- |
|
| Bill & Melinda Gates Foundation |
|
• • • |
2018-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
797,073 |
797,073 |
|
- |
|
| Medical Mutual Holdings, Inc. |
10% Owner |
– – • |
2018-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
160,445 |
160,445 |
|
- |
|
| Wakefield Group Iv, Llc |
10% Owner |
– – • |
2018-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
243,096 |
248,073 |
|
- |
|
| Zahir Fares |
10% Owner |
– – • |
2018-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,036,752 |
1,036,752 |
|
- |
|
| Barrett M James |
10% Owner |
– – • |
2018-07-30 |
4 |
B |
$11.00 |
$6,000,005 |
I/I |
545,455 |
2,484,870 |
1.5 |
- |
|
| Barrett M James |
10% Owner |
– – • |
2018-07-30 |
4 |
A |
$0.00 |
$0 |
I/I |
1,928,295 |
1,939,415 |
|
- |
|
| Kerins Patrick J |
10% Owner |
– – • |
2018-07-30 |
4 |
B |
$11.00 |
$6,000,005 |
I/I |
545,455 |
2,484,870 |
1.5 |
- |
|
| Kerins Patrick J |
10% Owner |
– – • |
2018-07-30 |
4 |
A |
$0.00 |
$0 |
I/I |
1,928,295 |
1,939,415 |
|
- |
|
| Bathurst Enterprises Ltd |
10% Owner |
– – • |
2018-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
100,713 |
100,713 |
|
- |
|
| Sandell Scott D |
10% Owner |
– – • |
2018-07-30 |
4 |
B |
$11.00 |
$6,000,005 |
I/I |
545,455 |
2,484,870 |
1.5 |
- |
|
| Sandell Scott D |
10% Owner |
– – • |
2018-07-30 |
4 |
A |
$0.00 |
$0 |
I/I |
1,928,295 |
1,939,415 |
|
- |
|
| Baskett Forest |
10% Owner |
– – • |
2018-07-30 |
4 |
B |
$11.00 |
$6,000,005 |
I/I |
545,455 |
2,484,870 |
1.5 |
- |
|
| Baskett Forest |
10% Owner |
– – • |
2018-07-30 |
4 |
A |
$0.00 |
$0 |
I/I |
1,928,295 |
1,939,415 |
|
- |
|
| Barris Peter J |
10% Owner |
– – • |
2018-07-30 |
4 |
B |
$11.00 |
$6,000,005 |
I/I |
545,455 |
2,484,870 |
1.5 |
- |
|
| Barris Peter J |
10% Owner |
– – • |
2018-07-30 |
4 |
A |
$0.00 |
$0 |
I/I |
1,928,295 |
1,939,415 |
|
- |
|
| Glaxosmithkline Plc |
Former 10% holder |
– – – |
2018-07-30 |
4 |
B |
$11.00 |
$1,636,998 |
I/I |
148,818 |
624,422 |
0.01 |
- |
|
78 Records found
|
|
Page 3 of 4 |
|
|
0.08 (0.66%) 
